GO CAPITAL Research
Investment Thesis
GO CAPITAL is a Rennes-based impact venture and growth capital manager founded in 2003 under the motto "sustainable innovation at the heart of the territories." It backs high-growth companies across digital, healthcare, cleantech, industry, and the maritime ("blue economy") sectors, with an explicit dual mandate of financial performance and positive regional impact: fostering responsible innovation, promoting sustainable projects, gathering committed investors, and strengthening local ecosystems in western and southern France. In June 2025, GO CAPITAL became a majority-owned subsidiary of Groupe MAGELLIM, a Paris-based impact private equity group that reached nearly €5 billion in assets under management and roughly 150 employees through the deal, while GO CAPITAL retained its Rennes-based team, brand, and investment mandate. The firm organizes its activity across territorial development funds, national/European sectoral impact vehicles (including an Impact Océan Capital fund dedicated to the blue economy), and advisory-mandate funds such as Mer Invest and Sud Mer Invest that extend its reach without direct fund ownership.
Sector Focus
GO CAPITAL's public portfolio is organized into five verticals: Health, Digital, Cleantech, Industry, and Marine economy. Representative recent and historical portfolio companies include BrightHeart (AI-assisted prenatal ultrasound), Alkion BioInnovations (sustainable bioproduction of vaccine adjuvants), PHAXIAM Therapeutics and Coave Therapeutics (biotech/gene therapy), BIOPHTA (ophthalmic treatments), Oxxius (laser photonics manufacturing), Sirius Neosight, United Visual Researcher/UVR (optical simulation software), Grain de Sail and Groupe Francbord (sustainable/maritime shipping and industrial technology), Lactips and MoEa (biomaterials and sustainable footwear), Comeen (hybrid workplace management), and Healshape, Osmosun, Sweetch Energy, and Biosency (cleantech and industrial monitoring).
Stage Focus
Across its territorial and impact funds, GO CAPITAL covers the full early-stage spectrum from seed ("capital-amorçage") through growth-stage capital-développement, typically entering at seed or Series A and reserving capital for follow-on rounds in existing portfolio companies.
Check Size
Disclosed recent round participations range from roughly €4-5M (Alkion BioInnovations €4.4M, Oxxius €5M) up to co-led growth rounds such as BrightHeart's €11M Series A, implying typical initial GO CAPITAL tickets in the low hundreds of thousands to a few million euros, with larger exposure built through follow-on reserves and syndication.
Lead Tendency
GO CAPITAL both leads regional/early deals (e.g., leading Alkion BioInnovations' financing alongside Critical Path Ventures) and co-invests in larger syndicated rounds (e.g., co-leading BrightHeart's Series A with Odyssée Venture and Sofinnova Partners, and backing Oxxius alongside Xplore by Épopée Gestion), so overall behavior reads as "both."
Recent Activity
GO CAPITAL remains in active-deployment mode following the 2025 MAGELLIM transaction. Confirmed recent activity includes: Alkion BioInnovations' €4.4M raise (November 2025), BrightHeart's €11M Series A co-led with Odyssée Venture and Sofinnova (January 2026), a BrightHeart/GE HealthCare Voluson Solution Store collaboration (February 2026), and Oxxius's €5M raise to fund international expansion through 2029 (September 2026).
Portfolio Highlights
Notable names span biotech (Alkion BioInnovations, PHAXIAM Therapeutics, Coave Therapeutics, Cryonove Pharma, BIOPHTA, ZEST), digital health and AI (BrightHeart), deeptech/hardware (Oxxius, Sirius Neosight, United Visual Researcher), and maritime/industrial technology (Groupe Francbord, Grain de Sail).
Team
GO CAPITAL's Directoire (executive board) comprises three Managing Partners:
- Bertrand Distinguin, Managing Partner
- Jérôme Gueret, Managing Partner
- Aude Kermarrec, Managing Partner
Front-office partners and investment team:
- Hervé Bachelot Lallier, David Leray, Alexis Ménard, Frédéric Le Brun, Frédéric Le Guillou, Guillaume Foillard — Partners
- Nathalie Peltier — Partner, Head of Compliance and Internal Control
- Leila Nicolas — Partner
- Anne Toupé, Alexandre Boulay, Clémentine Pécastaing, Damien Jouanneau — Investment Directors
- Pascale Liège, Margot Boulanger, Julien Louis — Senior Associates
- François Fauvin, Salah Chattabi, Guillaume Loudenot — Associates
- Malo Le Den, Valentin Fabre, Théophile Gallon — Analysts
- Éric Cozanet, Jean-Marc Herbert, Erwan Jacquin, Laurent Sassier, Carlos Campos, Esther Crauser Delbourg — Venture Partners
Decision Process
Investment decisions run through a partnership structure anchored by the three-person Directoire, typical of a mid-sized regional management company overseeing multiple fund vehicles.
Founder Preferences
GO CAPITAL favors technical and scientific founding teams building capital-intensive, "responsible innovation" with a regional or sectoral anchor: deep tech, biotech, industrial, and maritime-technology founders feature heavily, alongside digital-health and enterprise teams solving structuring problems rather than pure consumer plays.
Geographic Focus
Historically centered on the Grand Ouest of France (Brittany, Pays de la Loire, Haute-Normandie), GO CAPITAL now operates from Rennes, Nantes, Caen, Orléans, Tours, and Marseille, reflecting a broadened national footprint since joining Groupe MAGELLIM, while its territorial funds retain a regional development mandate.